Top News

Jan 02, 2015
BioPharm International
In 2014, FDA approved 41 new novel medications, which is the highest number since 1996.
Dec 29, 2014
BioPharm International
By BioPharm International Editors
Entrectinib has received FDA’s orphan drug and rare pediatric disease designations for the treatment of neuroblastoma.
Dec 29, 2014
BioPharm International
By BioPharm International Editors
When used in combination with chlorambucil to treat chronic lymphocytic leukemia, Gazyva was found to be more effective than Rituxan.
Dec 29, 2014
BioPharm International
By BioPharm International Editors
Roche’s LightMix Ebola test can give results in around three hours.
Dec 23, 2014
BioPharm International
Approval of anti-PD-1 antibody Opdivo represents a major milestone for patients who no longer respond to existing treatments for melanoma.
Dec 22, 2014
BioPharm International
Pharmacy benefit manager Express Scripts offers Viekira Pak at a discount and excludes the drug’s higher-priced competitors from its formulary.
Dec 19, 2014
BioPharm International
The first stem-cell medication approved in the EU promotes regeneration and healing to the outer layer of the cornea.
Dec 18, 2014
BioPharm International
Xencor's technology focuses on the use of antibody and protein biotherapeutics to treat immune-related diseases.
Dec 18, 2014
BioPharm International
By BioPharm International Editors
Fujifilm Diosynth Biotechnologies announced the completion of the acquisition of Kalon Biotherapeutics, a company that specializes in advanced biologics development manufacturing.
Dec 16, 2014
BioPharm International
The new bill calls for a data exclusivity period of 15 years for drugs that treat diseases with unmet medical need.
native1_300x100
lorem ipsum